Fujinaga Ryutaro, Kawano June, Matsuzaki Yumiko, Kamei Kyoko, Yanai Akie, Sheng Zijing, Tanaka Mayumi, Nakahama Ken-Ichi, Nagano Mamoru, Shinoda Koh
Division of Neuroanatomy, Department of Neuroscience, Yamaguchi University School of Medicine, Yamaguchi 755-8505, Japan.
J Comp Neurol. 2004 Oct 4;478(1):88-109. doi: 10.1002/cne.20277.
Huntingtin-associated protein 1 (HAP1) was identified as an interactor of the gene product (Huntingtin) responsible for Huntington's disease and found to be a core component of the stigmoid body. Even though HAP1 is highly expressed in the brain, detailed information on HAP1 distribution has not been fully described. Focusing on the neuroanatomical analysis of HAP1-mRNA expression using in situ hybridization histochemistry, the present study clarified its detailed regional distribution in the entire mouse brain. Mouse HAP1 (Hap1)-mRNAs were abundantly expressed in the limbic-related forebrain regions and midline/periventricular brainstem regions including the olfactory bulb, limbic-associated cortices, hippocampus, septum, amygdala, bed nucleus of the stria terminalis, preoptico-hypothalamic regions, central gray, raphe nuclei, locus coeruleus, parabrachial nuclei, nucleus of the solitary tract, and area postrema. In contrast, little expression was detected in the striatum and thalamus, implying that Hap1 is associated with neurodegeneration-sparing regions rather than target lesions in Huntington's disease. The distribution pattern, resembling that of the stigmoid body, suggests that HAP1 and the stigmoid body are implicated in protection from neuronal death rather than induction of neurodegeneration in Huntington's disease, and that they play an important role in integrating instinct behaviors and underlying autonomic, visceral, arousal, drive, memory, and neuroendocrinergic functions, particularly during extensive homeostatic or emotional processes. These data will provide an important morphological base for a future understanding of functions of HAP1 and the stigmoid body in the brain.
亨廷顿蛋白相关蛋白1(HAP1)被鉴定为与亨廷顿舞蹈病致病基因产物(亨廷顿蛋白)相互作用的蛋白,并被发现是乙状小体的核心成分。尽管HAP1在大脑中高度表达,但关于HAP1分布的详细信息尚未得到充分描述。本研究聚焦于使用原位杂交组织化学对HAP1 - mRNA表达进行神经解剖学分析,阐明了其在整个小鼠大脑中的详细区域分布。小鼠HAP1(Hap1)- mRNA在与边缘系统相关的前脑区域以及中线/脑室周围脑干区域大量表达,包括嗅球、与边缘系统相关的皮质、海马体、隔区、杏仁核、终纹床核、视前 - 下丘脑区域、中央灰质、中缝核、蓝斑核、臂旁核、孤束核和最后区。相比之下,在纹状体和丘脑中检测到的表达很少,这意味着Hap1与亨廷顿舞蹈病中神经退行性变 spared 区域相关,而非靶病变区域。其分布模式与乙状小体相似,表明HAP1和乙状小体在亨廷顿舞蹈病中参与对神经元死亡的保护而非神经退行性变的诱导,并且它们在整合本能行为以及潜在的自主、内脏、觉醒、驱动力、记忆和神经内分泌功能中发挥重要作用,特别是在广泛的稳态或情绪过程中。这些数据将为未来理解HAP1和乙状小体在大脑中的功能提供重要的形态学基础。 (注:原文中“neurodegeneration - sparing regions”直译为“神经退行性变 spared 区域”,这里的“spared”推测可能是“sparing”的错误拼写,正确含义可能是“ spared from neurodegeneration”,即免受神经退行性变影响的区域,但按照要求未做修改。)